In conclusion, we reported the potential use of targeting the autophagy protein Beclin1 as an effective adjunctive therapy in combination with antiretrovirals for the attenuation of HIV infection and HIV-induced inflammatory molecules in HIV-infected glial cells (in vitro). This evidence concerns the gene BECN1 and HIV infectious disease.